Leave a comment for the DEA
Until March 31st, 2023, you can leave a comment on the rule directly with the DEA. We’ve got a sample comment for you that you can use - but feel free to make it your own!
Be sure to reference “Docket No. DEA-948” in your comment and tell the DEA about the extra burden an in-person requirement places on patients and providers alike — as well as the increased risk of overdose if patients lose access to buprenorphine.”
To make it super easy, we've written a comment that you're welcome to use.
